Security of a Novel Antitapeworm Drug:Arecoline Hydrobromide  

Security of a Novel Antitapeworm Drug:Arecoline Hydrobromide

在线阅读下载全文

作  者:ZHOU Xu-zheng ZHANG Ji-yu LI Jin-shan LI Jian-yong WEI Xiao-juan NIU Jian-rong LI Bing 

机构地区:[1]Key Laboratory of New Animal Medicine Project, Lanzhou Institute of Animal Husbandry and Veterinary Medicine, Chinese Academy of Agricul-tural Sciences, Lanzhou 730050, China

出  处:《Animal Husbandry and Feed Science》2010年第2期26-28,31,共4页动物与饲料科学(英文版)

基  金:supported by Technology Development and Research Projects of Ministry of Science and Scientific Research Institutes(NCSTE-2006-JKZX-293);Science and Technology Major Projects in Gansu Province(2009GS02443);National Science and Technology Support Program of China (2008BADB4B05)

摘  要:[Objective] To make an objective evaluation about security of a new veterinary drug-arecoline hydrobromide according to the research results and papers in recent years and supply science basis for clinical usage. [ Method] The security of arecoline hydrobromide was evaluated based on acute toxicity tests; the ranges of safe medication, tolerability and toxicity as well as "Three-induced' effects (carcinogensis, mutagene- sis and teratogenesis) and reproductive toxicity were summarized according to the combinations of experimental results, papers and clinical effects. E Result] The results of acute toxicity tests in mice and rats showed that LD^0 (50% lethal dosages) of arecoline hydrobromide in mice was 691.83 mg/(kg.BW) and 95% incredible range of its LDso was 642.92 -744.47 mg/( kg. BW), and LDso of arecoline hydrobromide in rats was 2 054 mg/(kg.BW) and 95% incredible range of its LDso was 1 908 -2 210 mg/(kg.BW). Its LDso value was hundreds times higher than the recommen- ded clinical dosage [ 1 -5 mg/(kg-BW) ], therefore it is safe to apply in clinic. The research results of ranges of safe medication, tolerability and toxicity showed that arecoline hydrobromide could entirely dispel the dog Diphyllobothrium, Spirometra mansoni, Dipylidium mesocestoides, Linea- tus and Cysticercus at dosages of 2 -3 mg/( kg.BW), and the same effects to Railletina tapeworm of chickens and Drepanidotaenia lanceolata of duck and goose at dosages of I -2 mg/(kg.BW). The arecoline hydrobromide had muscarinic effects as side-effects and could cause vomiting, di- arrhea and other clinical symptoms to discharge the paralyzed worm from livestock body rapidly and completely. The arecoline hydrobromide had "Three-induced" effects and reproductive toxicity when it was used as antitapeworm drug with long-term, sustained and a large number of drug us- age, rather than used in clinical application with shorter time and lower dosage of administration. [ Conclusion] The arecoline hydrobromide is low[Objective] To make an objective evaluation about security of a new veterinary drug-arecoline hydrobromide according to the research results and papers in recent years and supply science basis for clinical usage. [ Method] The security of arecoline hydrobromide was evaluated based on acute toxicity tests; the ranges of safe medication, tolerability and toxicity as well as "Three-induced' effects (carcinogensis, mutagene- sis and teratogenesis) and reproductive toxicity were summarized according to the combinations of experimental results, papers and clinical effects. E Result] The results of acute toxicity tests in mice and rats showed that LD^0 (50% lethal dosages) of arecoline hydrobromide in mice was 691.83 mg/(kg.BW) and 95% incredible range of its LDso was 642.92 -744.47 mg/( kg. BW), and LDso of arecoline hydrobromide in rats was 2 054 mg/(kg.BW) and 95% incredible range of its LDso was 1 908 -2 210 mg/(kg.BW). Its LDso value was hundreds times higher than the recommen- ded clinical dosage [ 1 -5 mg/(kg-BW) ], therefore it is safe to apply in clinic. The research results of ranges of safe medication, tolerability and toxicity showed that arecoline hydrobromide could entirely dispel the dog Diphyllobothrium, Spirometra mansoni, Dipylidium mesocestoides, Linea- tus and Cysticercus at dosages of 2 -3 mg/( kg.BW), and the same effects to Railletina tapeworm of chickens and Drepanidotaenia lanceolata of duck and goose at dosages of I -2 mg/(kg.BW). The arecoline hydrobromide had muscarinic effects as side-effects and could cause vomiting, di- arrhea and other clinical symptoms to discharge the paralyzed worm from livestock body rapidly and completely. The arecoline hydrobromide had "Three-induced" effects and reproductive toxicity when it was used as antitapeworm drug with long-term, sustained and a large number of drug us- age, rather than used in clinical application with shorter time and lower dosage of administration. [ Conclusion] The arecoline hydrobromide is low

关 键 词:Arecoline hydrobromide Acute toxicity "Three-induced" effects Reproductive toxicity 

分 类 号:S948[农业科学—水产养殖] TQ460.69[农业科学—水产科学]

 

参考文献:

正在载入数据...

 

二级参考文献:

正在载入数据...

 

耦合文献:

正在载入数据...

 

引证文献:

正在载入数据...

 

二级引证文献:

正在载入数据...

 

同被引文献:

正在载入数据...

 

相关期刊文献:

正在载入数据...

相关的主题
相关的作者对象
相关的机构对象